Skip to main content
. 2015 Aug 10;33(44):5997–6010. doi: 10.1016/j.vaccine.2015.07.101

Fig. 5.

Fig. 5

(a) Scheme of the sustain release of the antigen using chitosan-PLA microneedle array. (b) OVA-specific IgG levels of rats after a single dose of antigen: saline (non-immunized group), IM (intramuscular administration) and MN (microneedle administration) [106].